Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|January 3, 2025
MVA-based SARS-CoV-2 vaccine candidates encoding different spike protein conformations induce distinct early transcriptional responses which may impact subsequent adaptive immunityIlka Grewe, Monika Friedrich, Marie-Louise Dieck, et al.
Transboundary and Emerging Diseases|November 16, 2020
Multi-species ELISA for the detection of antibodies against SARS-CoV-2 in animalsKerstin Wernike, Andrea Aebischer, Anna Michelitsch, et al.
Frontiers in Immunology|March 26, 2026
Immunization with MVA-based vaccines protects K18-hACE2 mice from SARS-CoV-2 infection-associated inflammatory lesions in brainsMałgorzata Rosiak, Sabrina Clever, Eva Leitzen, et al.
Scientific Reports|August 19, 2017
Modified Vaccinia Virus Ankara Preferentially Targets Antigen Presenting Cells In Vitro, Ex Vivo and In VivoArwen F Altenburg, Carolien E van de Sandt, Bobby W S Li, et al.
NPJ Vaccines|January 26, 2024
MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humansLeonie Mayer, Leonie M Weskamm, Anahita Fathi, et al.
Journal of Virology|September 2, 2016
Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 MiceArwen F Altenburg, Carolien E van de Sandt, Stella E van Trierum, et al.
Virology|June 25, 2025
Synergistic interference with SARS-CoV-2 replication by molnupiravir-derived N4-hydroxycytidine and inhibitors of CTP synthetase in cell cultureKim M Stegmann, Antje Dickmanns, Hannah L Fuchs, et al.
Emerging Infectious Diseases|June 21, 2021
Prolonged SARS-CoV-2 RNA Shedding from Therapy Cat after Cluster Outbreak in Retirement HomeClaudia Schulz, Claudia Wylezich, Kerstin Wernike, et al.
Science (New York, N.Y.)|December 19, 2015
An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camelsBart L Haagmans, Judith M A van den Brand, V Stalin Raj, et al.
Viruses|July 27, 2022
An Equine Model for Vaccination against a Hepacivirus: Insights into Host Responses to E2 Recombinant Protein Vaccination and Subsequent Equine Hepacivirus InoculationMarcha Badenhorst, Armin Saalmüller, Janet M Daly, et al.
Pageof 7